A pacemaker is another surgically implanted medical device is another option for treating hypertrophic cardiomyopathy by monitoring heart rhythm.
A pacemaker can be implanted using a very similar procedure to how an ICD is placed. Early trials of pacemaker therapy in hypertrophic cardiomyopathy suggested a significant benefit from simply changing the activation sequence of heart contraction. Although the pressure build up was decreased in most studies, it turned out that this did not translate to benefit the patients, so pacing as a therapy is not routinely recommended. However, in certain subsets of patients, it can be helpful. Newer technologies may result in further trials of this approach.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.